skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: What is a solid level of free cash flow a company should deliver and what are your favoured 5 stocks in each of Canada and the US with high free cash flow? Thank you.
Read Answer Asked by Michael on March 22, 2022
Q: The Trade Desk presently has sales of 86% in North America and 14% in international. The president believes that in the long run, international will become a bigger part of the overall revenues which is promising.

On the other side I see a strong growth in stock base compensation every year. In 2018 there was around 424 M of stock and now it is more than 500 M. No acquisitions were made to dilute shareholders and there is no buyback at the moment. They could put one in place in the future since they have 1 B in cash and no debt.

I know that stock base compensations is a way to acquire and retain strong talents but do you believe that it is bad for us as shareholders ?
Read Answer Asked by jean on March 22, 2022
Q: Can you please give me your recommendation on a defence stock or stocks that you like at this time when many countries will be increasing their defence budgets. Thank You.
Read Answer Asked by Brian on March 22, 2022
Q: Hi team. I was fortunate to add to my Nvdia position at $219 a couple of weeks ago. Nvdia has now grown to 7% of my investment portfolio (stocks) and 6% of my total portfolio. I know you can’t get specific with weightings. I do see you typically trim your balance model portfolio around 8% when a winner runs.

Thoughts on how you decide to trim a winner and when?
Read Answer Asked by Don on March 22, 2022
Q: Good morning 5i

I am wavering between these two. I already own some abbivie. But I hesitate because it has shot up recently. I know you favour it. But I have seen several people lately, today Brian Acre, leaning towards bmy. Here is the reasoning of one such person:

The company has a strong pipeline of new drugs, but also a lot of patent expirations for its big existing drugs coming up, which means the company has to effectively rotate its portfolio of revenue-producing drugs in the coming years. To offset that risk, it is priced very cheaply, with a single-digit price/earnings ratio and a solid dividend yield. I think the current price offers a good accumulation zone.

I am wondering about your different approaches. Would it be that you favour growth more and they are looking for safe income?
Thanks as always
Read Answer Asked by joseph on March 21, 2022
Q: I was wondering if you could provide any commentary on the newly spun-out company, ZImVie (formerly from Zimmer Biomet). I am familiar with their dental products - they are quite good, and focus primarily on the implant space (including implant fixtures, prosthetic components for tooth replacement and bone regeneration materials), rather than a more diversified product line throughout the dental space. I have spoken to a representative from the company, and my limited understanding is that it seems likelier that they plan to stay focused in this segment of dental health for the foreseeable future.

My question would be as follows: given the limited amount of time they have existed as a stand-alone company, can enough be gleaned from what is publicly available to make an informed decision regarding their longer-term prospects? At this point, I only have the worm’s-eye view (I use their products and like them, as well as their clinical support system), and I could really use a bird’s-eye vantage point. Thanks so much, and I look forward to reading you comments!
Read Answer Asked by Domenic on March 21, 2022
Q: Good morning. I am looking to add a new US dividend growth stock to my RRSP. My top contenders are Costco, Home Depot and McDonald's. What would be your top choice today? Do you have any better suggestions (stocks or REIT's)? Thank you.

Kim
Read Answer Asked by Kim on March 21, 2022
Q: Good Morning. I am selling off some of my more volatile US tech stocks in my RRIF and am looking to redeploy the proceeds into US stable Dividend payors. Can you please suggest 5 or 6 US Dividend stocks ( other than US Tech) to look at? Thanks
Read Answer Asked by Peter on March 21, 2022
Q: Hello Peter et al,

You have mentioned in the past that Amazon needs Shop or it runs into monopoly problems and that Shop has a strong moat.

When I look at the size difference Amazon has 14x the market cap and 1500x the employees.

When I look at stock price Amazon has been a steady climber with a minimal hit over the past 6 months vs Shop being more than halved in mkt cap.

If I were CEO of Amazon reviewing the co. dashboards and heatmaps - I think I would look at the Shopify roadmap and see either noise or an opportunity we could setup for and pre-empt (if that business is on our roadmap).

How scalable is Shop given that Amazon has a long track record, the most money and supply chains to the best strategic minds?
How sustainable is the Shop competitive advantage?

I ask this wondering how likely Shop is to regain the lofty $2000 level.

Thank you for sharing your insight.

Read Answer Asked by Delbert on March 21, 2022
Q: I own all of these high multiple tech stocks in low quantities in tfsas. No particular concern about timelines. Would you continue to advise holding all of them or would you suggest eliminating one or more for the other? Is there a simple way to compare?
Read Answer Asked by Peter on March 18, 2022
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!